Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
Global Acute Myeloid Leukemia (AML) Therapeutics Industry
05:22am, Friday, 17'th Apr 2020
New York, April 17, 2020 -- Reportlinker.com announces the release of the report "Global Acute Myeloid Leukemia (AML) Therapeutics Industry" -.
Jazz Pharmaceuticals (JAZZ) Receives a Buy from Oppenheimer
07:12pm, Thursday, 16'th Apr 2020
In a report released today, Esther Rajavelu from Oppenheimer maintained a Buy rating on Jazz Pharmaceuticals (JAZZ), with a price target of $154.00. The
Jazz Pharmaceuticals (JAZZ) Receives a Buy from Oppenheimer
07:11pm, Thursday, 16'th Apr 2020
In a report released today, Esther Rajavelu from Oppenheimer maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report),
Utah Jazz Fan Favorites And Glue Guys From The Last Decade
01:18pm, Thursday, 16'th Apr 2020
With Utah Jazz fan favorite Trevor Booker announcing his retirement, who are some other beloved Jazz players from recent seasons?
BRIEF-Jazz Pharma Says Porton Biopharma Entered Into New Agreement With New Partner To Commercialize & Distribute Erwinaze
11:15am, Thursday, 16'th Apr 2020
Jazz Pharmaceuticals PLC:
FY2020 EPS Estimates for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Reduced by SVB Leerink
06:14am, Thursday, 16'th Apr 2020
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Equities researchers at SVB Leerink reduced their FY2020 EPS estimates for shares of Jazz Pharmaceuticals in a research note issued on Monday, April 13th. SV
Guggenheim Capital LLC Has $12.07 Million Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
10:38am, Wednesday, 15'th Apr 2020
Guggenheim Capital LLC lifted its stake in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 44.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange
Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA), informed Alvogen Malta Operations Ltd., the Company’s commercialization partner for PF708, via a G
Ladenburg Thalmann Financial Services Inc. Decreases Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
11:24am, Tuesday, 14'th Apr 2020
Ladenburg Thalmann Financial Services Inc. lowered its stake in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 23.4% in the 4th quarter, according to the company in its most recent 13F filing wit
Franklin Resources Inc. Sells 495,998 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
09:46am, Tuesday, 14'th Apr 2020
Franklin Resources Inc. decreased its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 99.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and
Boenning & Scattergood Inc. Takes $299,000 Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
09:04am, Tuesday, 14'th Apr 2020
Boenning & Scattergood Inc. bought a new stake in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commissi
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Rating of "Buy" by Brokerages
06:46am, Tuesday, 14'th Apr 2020
Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received an average rating of “Hold” from the twenty-two analysts that are presently covering the stock, MarketBeat reports. Two investment an
The other possible COVID drug: How a biotech giant jumped into the coronavirus fray
02:29pm, Monday, 13'th Apr 2020
Dr. Mark Eisner is senior vice president for product development in immunology, infectious diseases and ophthalmology for Genentech.
How Mike Conley Can Win ESPN’s HORSE Tournament
03:16pm, Sunday, 12'th Apr 2020
Sunday night will mark the debut of ESPN’s NBA HORSE tournament, and Utah Jazz point guard Mike Conley will be among the eight participants. Here are the shots he should use to emerge victorious.
